Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of activated T cell autonomous cell death. [GOC:add, GOC:mtg_apoptosis, ISBN:0781765196]
Positive regulation of activated T cell autonomous cell death is a tightly controlled biological process that ensures the elimination of activated T cells once their function is no longer required or when they become harmful. This process is essential for maintaining immune homeostasis and preventing autoimmune diseases. Here's a detailed description:
**1. Activation of T cells:** T cell activation occurs when antigen-presenting cells (APCs), such as dendritic cells, present antigens to T cells via the MHC-peptide complex. This interaction triggers signaling pathways that activate T cells, leading to their proliferation and differentiation into effector T cells.
**2. Induction of apoptosis:** Once T cells are activated, they are susceptible to apoptosis, a programmed cell death process. This sensitivity is a critical mechanism to prevent prolonged immune responses and potential damage to healthy tissues. Several pathways can trigger apoptosis in activated T cells:
**a. Withdrawal of survival signals:** During T cell activation, survival signals are provided by cytokines like IL-2. When these signals are withdrawn, T cells become susceptible to apoptosis.
**b. Fas-FasL interaction:** Activated T cells express the Fas receptor (CD95) on their surface. Upon interaction with its ligand, FasL, expressed on other immune cells like activated T cells or NK cells, a signaling cascade is initiated, leading to caspase activation and apoptosis.
**c. TNF-α pathway:** Tumor necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine that can induce apoptosis in activated T cells. TNF-α binds to its receptor, TNFR1, on T cells, triggering a signaling pathway that results in caspase activation and apoptosis.
**d. Granzyme B:** Cytotoxic T lymphocytes (CTLs) release granzyme B, a serine protease, which enters target cells through perforin pores. Granzyme B cleaves and activates caspase enzymes, ultimately leading to apoptosis.
**3. Role of regulatory T cells (Tregs):** Tregs play a crucial role in regulating T cell activation and apoptosis. Tregs express the inhibitory molecule CTLA-4, which binds to CD80/CD86 on APCs and inhibits T cell activation and proliferation. Tregs also produce cytokines like IL-10 and TGF-β, which suppress T cell activation and induce apoptosis.
**4. Importance of positive regulation of activated T cell autonomous cell death:**
**a. Maintaining immune homeostasis:** Apoptosis of activated T cells is essential for preventing excessive immune responses and maintaining balance in the immune system.
**b. Preventing autoimmune diseases:** Dysregulation of T cell apoptosis can lead to the accumulation of autoreactive T cells, increasing the risk of autoimmune disorders.
**c. Controlling inflammatory responses:** Apoptosis of activated T cells helps to control inflammation and prevent tissue damage.
**d. Eliminating exhausted T cells:** Exhausted T cells are T cells that have been chronically exposed to antigen and have lost their effector functions. Apoptosis of exhausted T cells allows for the replacement with new, functional T cells.
**5. Therapeutic implications:**
**a. Cancer immunotherapy:** Understanding T cell apoptosis mechanisms can inform the development of therapies that enhance T cell survival and antitumor activity.
**b. Autoimmune disease treatment:** Therapies that target specific pathways involved in T cell apoptosis can potentially control autoimmune disease by eliminating autoreactive T cells.
**In conclusion, the positive regulation of activated T cell autonomous cell death is a vital process that ensures proper immune function and prevents harmful immune responses. Its dysregulation is implicated in various immune disorders, making it an important target for therapeutic interventions.**'
"
Protein | Definition | Taxonomy |
---|---|---|
Galectin-9 | A galectin-9 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O00182] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
lactose | beta-lactose : The beta-anomer of lactose. lactose : A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form. Lactose: A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. | lactose | |
methyl alpha-d-galactopyranoside | methyl alpha-D-galactoside : An alpha-D-galactoside having a methyl substituent at the anomeric position. methyl-galactopyranoside: structure in first source | alpha-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
methyl beta-galactoside | methyl beta-D-galactoside : A beta-D-galactopyranoside having a methyl substituent at the anomeric position. methyl beta-galactoside: RN given refers to (beta-D)-isomer methyl galactoside : A methyl glycoside in which the H of the OH group on C-1 of galactose is replaced by a methyl group. | beta-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
thiodigalactoside | thiodigalactoside: RN given refers to beta-D-galactopyranoside (D-Gal)-isomer | ||
methyl lactoside | beta-D-Gal-(1->4)-beta-D-Glc-OMe : A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position. | disaccharide derivative; methyl glycoside | |
n-acetyllactosamine | N-acetyllactosamine : A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. N-acetyllactosamine: RN given refers to D-isomer | beta-D-Galp-(1->4)-D-GlcpNAc | |
galactal | galactal: RN given refers to cpd with unspecified isomeric designation; structure | anhydrohexose; glycal |